Wuhan (Novel) Corona Virus -looming pandemy of deadly pneumonia? - Pandemy ongoing!

(December 26, 2020) UK scientists trial instant immunity antibody drug treatment for Covid-19
The University College London Hospitals NHS Trust (UCLH) said that the researchers in the Storm Chase study
believe a Long Acting AntiBody (LAAB) known as AZD7442, developed by AstraZeneca, may offer immediate and long-term protection
to people who have been recently exposed to the SARS-CoV-2 coronavirus and prevent them developing Covid-19.
UCLH said its new vaccine research centre is running two clinical trials testing a LAAB combination treatment to protect against Covid-19.
The second Provent study is looking at the use of AZD7442 in people who may not respond to vaccination,
for instance where someone has a compromised immune system or are at increased risk of Covid-19 infection due to factors such as age and existing conditions.
Antibodies are protein molecules that the body produces to help fight infections.
Monoclonal antibodies are artificially produced in a laboratory and designed as possible medical treatments.
They are designed to be injected directly into the body, unlike vaccines which “train” the immune system itself to produce antibodies.

KneelB4Zod! wrote:Lebanese News and Updates
@LebanonaME
·
1m
Israeli media reports a death of an elderly, two hours after getting vaccinated for COVID-19.

The health Ministry is investigating.

"A 70-year-old man dies two hours after being vaccinated against Corona, Ministry of Health claims: There is no link between death and the vaccine"

https://www.mako.co.il/news-lifestyle/2020_q4/Article-24211e884c8a671026.htm

(December 24, 2020) CDC To Require Negative Covid-19 Tests For Airline Passengers Entering U.S. From UK
Airline passengers heading to the U.S. from the UK must test negative for COVID-19 before departure, the Centers for Disease Control said late Thursday.
Airline passengers from the United Kingdom will need to get negative COVID-19 tests within three days of their trip
and provide the results to the airline, the CDC said in a statement. If a passenger chooses not to take a test,the airline must deny boarding
to the passenger. The agency said the order will be signed today, December 25, and go into effect on Monday.
This week, New York Gov. Andrew Cuomo clinched an unusual agreement with three airlines with flights from London to New York – Delta,
British Airways and Virgin Atlantic — which agreed to test passengers flying from the UK to New York.
On Thursday, United Airlines agreed to do the same for its flights to Newark, NJ.

Asymptomatic transmission of COVID-19 didn’t occur at all, study of 10 million finds

https://www.lifesitenews.com/news/asymptomatic-transmission-of-covid-19-didnt-occur-at-all-study-of-10-million-finds


So every healthy, aymptomatic person, forced to isolation because of "positive" test result was stripped of civil rights for no reason. In adition, everyone, who is forced to wear face mask, can't visit pub or meet with friends, is also harrased for no reason. Governments must be held responsible for thi.

(December 28, 2020) Korea secures COVID-19 vaccines via deals with Janssen, Pfizer
The Korean government has concluded deals with global pharmaceutical giants Janssen of Johnson and Johnson and Pfizer
to purchase vaccines against COVID-19 for its population. Prime Minister Chung Sye-kyun announced the progress in a press release held on 24 Dec 2020.
"The deal with Janssen will bring in six million doses, or two million more than originally planned.
We will start administering them from next year's second quarter.
Government agreed to import 10 million vaccine doses from Pfizer from the third quarter next year.
Korean government has secured vaccines for ten million people from the COVAX facility along with another 34 million doses from pharmaceutical companies.

(December 28, 2020) Australia rolls out strategies for COVID-19 vaccine supply and distribution
Australian Government has announced that it has signed contracts with the companies to partner for safe distribution of COVID-19 vaccines to all Australians
from March next year and completion of the whole of the population in 2021.
The contracts cover three vital aspects of the vaccine rollout:
1. Distribution and logistics:
- DHL Supply Chain
- Linfox
2. Data tracking of vaccine doses as well as enabling overall program implementation monitoring:
- Accenture
3. The vaccine rollout partner:
- PwC
Data partner Accenture will design, develop, and implement a software solution to enable “point in time”
visibility of COVID-19 vaccine doses across the delivery chain. This will include receipt of the vaccine by health services,
vaccination of patients, and subsequent monitoring for adverse reactions. Australia Government has secured over 117 million doses
to cover the Australian population several times over.

(December 1, 2020) Amazon delves deeper into voice recognition, call-center work as COVID-19 drives cloud
Amazon.com Inc AMZN.O on Tuesday announced voice recognition
as part of a suite of call-center services for businesses,
as the company sees growing demand for its cloud tools during the coronavirus pandemic.
Speaking at the company's annual re:Invent conference, executive Andy Jassy announced Amazon Connect Voice ID,
which uses machine learning software to authenticate customers who dial into call centers.
Jassy, who runs the firm's cloud computing division Amazon Web Services, said AWS builds a voice print
for customers who opt in to save time on calls.

(December 28, 2020) Karnataka health minister hints at police action against untraceable UK returnees
Karnataka Health Minister Dr K Sudhakar on Monday hinted at stringent action
against those returnees from the United Kingdom who were untraceable and had switched off their mobile phones.
“I request the UK returnees to cooperate with us as responsible citizens. You have to get tested.
If you don’t get tested and switch off your phone, then it’s a crime in true sense,” Sudhakar told reporters here.
It could even be police action against them, the minister indicated.

ER nurse tests positive for COVID-19 eight days after receiving vaccine

https://www.10news.com/news/local-news/er-nurse-tests-positive-for-covid-19-eight-days-after-receiving-vaccine

WHO warns vaccinated travellers could still need to be quarantined

"WHO's chief scientist Dr Soumya Swaminathan told a virtual press conference that there was no evidence yet that people who had been vaccinated could enter countries such as Australia without the risk of spreading the disease."

https://www.smh.com.au/world/europe/who-warns-vaccinated-travellers-could-still-need-to-be-quarantined-20201229-p56qk3.html

ussuricat
@ussuricat1
·
3m
V@X Passports in Russia
"Starting January, Russians who have been vaccinated against coronavirus will be able to automatically receive a passport of the vaccinated on the portal of public services. "

https://tass.ru/obschestvo/10376383

MSM deathly silent as PCR test legally ruled useless to test for Covid

"Four German holidaymakers who were illegally quarantined in Portugal after one was judged to be positive for Covid-19 have won their case, in a verdict that condemns the widely-used PCR test as being up to 97-percent unreliable."

"Unreliable, with a strong chance of false positives"

"The deliberation of the Lisbon Appeal Court is comprehensive and fascinating. It ruled that the Azores Regional Health Authority had violated both Portuguese and international law by confining the Germans to the hotel. The judges also said that only a doctor can “diagnose” someone with a disease, and were critical of the fact that they were apparently never assessed by one."

https://www.nexusnewsfeed.com/article/geopolitics/msm-deathly-silent-as-pcr-test-legally-ruled-useless-to-test-for-covid


Verdict:

https://drive.google.com/file/d/1t1b01H0Jd4hsMU7V1vy70yr8s3jlBedr/view?fbclid=IwAR0L_Iu6wwIVfFlZpykLhDHroS12MHZqO533Uizzc-5ZfUUmALOOjY58he4

(December 28, 2020) 23andMe Raises More Than $80 Million in Equity Financing Round
DNA testing company 23andMe Inc. raised more than $80 million in equity in a financing round led by Sequoia Capital and NewView Capital.
According to Securities and Exchanges Commission filings, the company offered $85 million in equity and sold about $82.5 million.
Previously, the company had raised about $791 million. In recent years, 23andMe has begun moving beyond
telling individual consumers about their DNA and begun work developing therapeutics based on research into genetic information
its customers provide. For example, the company has used its data to find genetic differences
that can affect a person’s susceptibility to Covid-19.

(December 17, 2020) You can’t sue Pfizer or Moderna if you have severe Covid vaccine side effects. The government likely won’t compensate you for damages either
If you experience severe side effects after getting a Covid vaccine, lawyers tell CNBC there is basically no one to blame in a U.S. court of law.
The federal government has granted companies like Pfizer and Moderna immunity from liability if something unintentionally goes wrong with their vaccines.
You also can’t sue the Food and Drug Administration for authorizing a vaccine for emergency use,
nor can you hold your employer accountable if they mandate inoculation as a condition of employment.
In February, Health and Human Services Secretary Alex Azar invoked the Public Readiness and Emergency Preparedness Act.
The 2005 law empowers the HHS secretary to provide legal protection to companies making or distributing
critical medical supplies, such as vaccines and treatments, unless there’s “willful misconduct” by the company. The protection lasts until 2024.
HHS declined CNBC’s request for an interview.

(December 28, 2020) Introducing COMIRNATY, the EU Brand Name for Pfizer & BioNTech's COVID-19 Vaccine, Developed by Brand Institute
Brand Institute, the global leader in pharmaceutical and healthcare related name development,
is proud to announce its role in naming Pfizer and BioNTech's COVID-19 vaccine: COMIRNATY (koe mir' na tee).
The name was first announced by Swiss regulatory authority, Swissmedic.
Shortly after, it was included in the conditional marketing authorization published by the European Medicines Agency (EMA).
“The name is coined from Covid-19 immunity, and then embeds the mRNA in the middle, which is the platform technology,
and as a whole the name is meant to evoke the word community,” Scott Piergrossi, Brand Institute president of operations and communications, said.

(May 23, 2020) Dr Harsh Vardhan elected as WHO's Executive Board chairman
New Delhi: Dr Harsh Vardhan, Minister of Health and Family Welfare, India,
was today elected the Chair of World Health Organization’s(WHO) Executive Board.
WHO’s Executive Board comprises of 34 members elected for three-year terms.
The Chair of the Executive Board is elected by its members on being nominated
by the Regional Committees of the six WHO Regions, by rotation.
At the 72nd Regional Committee Session of WHO South-East Asia in September 2019,
Member States had nominated India to be member of the WHO Executive Board from the Region to replace Sri Lanka
whose term expired in May 2020 and also to lead 147th and 148th Sessions of the Executive Board as Chairperson.
The other countries from WHO South-East Asia Region in the Executive Board are Bangladesh (2019-2022) and Indonesia (2018-2021).
Dr Harsh Vardhan, who took over from Dr Hiroki Nakatani of Japan, would chair the 148th session of the Executive Board in January 2021.

(December 30, 2020) Union Health Minister Dr. Harsh Vardhan nominated to the Board of GAVI, The Vaccine Alliance
Dr. Harsh Vardhan, Union Minister of Health and Family Welfare has been nominated
by the Global Alliance for Vaccines and Immunisation (GAVI) as a member on the GAVI Board.
The GAVI Board is responsible for strategic direction and policy-making,
oversees the operations of the Vaccine Alliance and monitors programme implementation.
With membership drawn from a range of partner organisations, as well as experts from the private sector,
the Board provides a forum for balanced strategic decision making, innovation and partner collaboration.
Dr. Ngozi Okonjo-lweala presently serves as Chair of the GAVI Alliance Board.

(December 30, 2020) Covid-19: Oxford-AstraZeneca vaccine approved for use in UK
The Oxford-AstraZeneca vaccine has been approved for use in the UK, with the first doses due to be given on Monday.
The UK has ordered 100 million doses of the new vaccine - enough to vaccinate 50 million people.
The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised two full doses
of the Oxford vaccine, with the second dose to be given four to 12 weeks after the first.
Prime Minister Boris Johnson has hailed the latest vaccine development as "a triumph"
for British science, adding: "We will now move to vaccinate as many people as quickly as possible."

zerohedge
@zerohedge
·
1h
At Least 3 Shipments Of COVID Vaccine Have Spoiled On Their Way To Texas

https://www.zerohedge.com/covid-19/least-3-shipments-covid-vaccine-have-spoiled-their-way-texas

OffGuardian
@OffGuardian0
·
7s
WATCH: The Future of Vaccines

https://off-guardian.org/2020/12/30/watch-the-future-of-vaccines/

Oh boy what a shot
@ohboywhatashot
·
1m
Person who was among the first in Switzerland to be vaccinated with a COVID19 vaccine later died.

"a link between the death and the COVID-19 vaccine was highly unlikely," the regulator said"

https://mobile.reuters.com/article/amp/idUSKBN29413Y?taid=5fec6f53047c5c0001cc1179&utm_campaign=trueAnthem%3A

Lol sure! That's another person dead shortly after vaccination we know about. How many was sept under the carpet we don't know yet...

(December 30, 2020) Bolivia signs contract with Russia to acquire 5.2 million dosis of the Sputnik V COVID-19 vaccine.
The Government of Bolivia signed this Wednesday an agreement with Russia
to acquire 5.2 million doses of the Sputnik V vaccine against the coronavirus.
He said that the vaccines they will acquire with Russia "are additional"
to those they will obtain with the COVID-19 Global Access to Vaccines Fund (Covax).
With this signature, Bolivia becomes the third Latin American country to sign an agreement
for the purchase of the drug, after Argentina, which has already begun vaccination, and Venezuela,
which is participating in phase III of its clinical trial and announced its acquisition on Tuesday.

(December 31, 2020) China approves first self-developed COVID-19 vaccine
China announced on Thursday that it had granted conditional marketing authorization for its first self-developed COVID-19 vaccine.
The inactivated vaccine, which got the approval from the National Medical Products Administration (NMPA),
is developed by the Beijing Biological Products Institute Co., Ltd.
under the China National Biotec Group (CNBG), which is affiliated with Sinopharm.
China approved the emergency use of COVID-19 vaccines in June, targeting groups with high risks of infection.
On Dec. 15, China officially launched a vaccination program for this winter-spring period targeting a number of key groups,
including those engaged in handling imported cold-chain products, customs officers, medical workers and people working in public transport and fresh markets.

(December 21, 2020) IBM links with Salesforce to offer digital COVID-19 vaccine passports
"At the start of the pandemic, many organizations deployed simple COVID-19 screenings, such as self-reported health surveys,
to support re-entry to workplaces and other institutions," said Paul Roma, general manager of IBM Watson Health.
"Now, as testing becomes more widespread and vaccine distribution gets underway, we are expanding the availability of IBM Digital Health Pass with Salesforce
to help organizations verify an individual's vaccine status and any other relevant health credentials," Roma said.
Big Blue’s health pass app, which debuted earlier this year, aims to provide individual, sharable health credentials following test results, vaccinations
and temperature checks through an encrypted digital wallet on a smartphone. This could also help allow passengers to board airplanes,
concertgoers to enter venues or spectators to attend sporting events. Salesforce also recently introduced a version of Work.com for managing vaccine programs
aimed at governments and healthcare organizations. The company is also working with Gavi, the Vaccine Alliance
to help distribute about 2 billion doses of coronavirus vaccines across 190 countries before the end of next year.

(December 28, 2020) NIH grants $1.5M to Soligenix
Soligenix Inc. reported today that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH),
has awarded the company a Direct to Phase 2 Small Business Innovation Research (SBIR) grant of around $1.5 million.
The grant is intended to support the manufacture, formulation, and characterization of COVID-19 and ebola virus vaccine candidates,
in conjunction with the CoVaccine HT adjuvant. The award will also support immune characterization of this emulsified adjuvant
with unique potency and compatibility with lyophilization strategies, in order to enable the thermostabilization of subunit vaccines.

(December 31, 2020) World Economic Forum report lauds Karnataka’s BBMP COVID-war room expertise along with six other cities
Karnataka’s BBMP (Bengaluru Bruhat Mahanagara Palike) COVID-war room has been appreciated by the World Economic Forum
for its leverage of technology to fight COVID-19 along with six others: Surat, Pimpri-Chinchwad, Tel Aviv, Lisbon and New York City.
In a report titled 'Technology and Data Governance in Cities released by the World Economic Forum indicated on how Bengaluru
was unprepared for the sudden growth of COVID-19 cases and had to quickly scale up to coordinate and offset the challenge.
B H Anil Kumar, former BBMP commissioner who is the face behind setting up this war room
had stated that just as the coronavirus disease broke out the city in early March,
Bengaluru was ill-prepared in terms of infrastructure to track the pandemic.
Corporate majors including Infosys, PWC, Quantella, ESRI India, CWC India and Microsoft chipped in their expertise.

(December 31, 2020) WHO grants emergency use approval for Pfizer Covid-19 vaccine
The World Health Organization on Thursday granted emergency validation to the Pfizer-BioNTech vaccine,
paving the way for countries worldwide to quickly approve its import and distribution.
The decision "makes the Pfizer/BioNTech vaccine the first to receive emergency validation from WHO
since the (novel coronavirus) outbreak began a year ago," WHO said in a statement.
Britain launched its inoculation drive with the US-German vaccine on December 8, with the United States, Canada and EU countries following suit.

(January 1, 2021) Taiwan secures 10 M doses of AstraZeneca COVID-19 vaccine
Taiwan's Health Minister and Central Epidemic Command Center (CECC)
has announced that the country has purchased 20 million doses of coronavirus vaccines,
including 10 million from AstraZeneca. Taiwan is also developing three of its own domestic vaccines.
Head of CECC, Chen Shih-chung said that the center has negotiated the purchase of 20 million doses of vaccines,
including 4.76 million doses through the COVAX global initiative and 10 million doses of the Oxford/AstraZeneca vaccine.
Chen estimates that the center will begin inoculating Taiwanese residents with these vaccines by March of 2021.
In addition, discussions with several other foreign vaccine makers who have entered Phase III trials are ongoing.

(January 1, 2021) Expert panel approves Serum Institute's (SII) Covid-19 vaccine for emergency use
An Indian regulatory expert panel on Friday recommended emergency use authorization of the AstraZeneca-Oxford vaccine against Covid-19
manufactured by Serum Institute in India - clearing the decks for an unprecedented campaign aimed at vaccinating
30 crore people in the next few months. Sources said the approval for the first Indian Covid-19 vaccine
came from the Central Drug Standards and Control Organisation’s subject expert committee after lengthy presentation
by the company officials and detailed deliberations on the data they shared with the experts. There was no need for an efficacy evaluation
for which the data considered by the UK regulatory authority for the Oxford-Astra vaccine, was perused by the Indian experts.
But there is no clarity at the moment on what the gap between the two shots would be whether the two shots will be administered
four weeks apart as per the protocol or three months apart as decided by the UK government. There is also no clarity on the dosing schedule.
The CDSCO panel also heard a presentation from Bharat Biotech, Hyderabad on the homegrown Covid-19 vaccine but didn’t take a decision.